{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:30:29Z","timestamp":1794540629400,"version":"4.9.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1038\/s41409-025-02719-7","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:28:54Z","timestamp":1758803334000},"page":"1622-1627","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The role of splenic irradiation prior to allogeneic hematopoietic stem transplantation in myelofibrosis: a review of the literature"],"prefix":"10.1038","volume":"60","author":[{"given":"Mostafa F.","family":"Mohammed Saleh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9401-810X","authenticated-orcid":false,"given":"Abdulrahman","family":"Nasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Alshabanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser","family":"Khafaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahemd","family":"Kotb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3942-7370","authenticated-orcid":false,"given":"Mahmoud","family":"Aljurf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"2719_CR1","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1016\/s2352-3026(22)00330-1","volume":"10","author":"N Polverelli","year":"2023","unstructured":"Polverelli N, Hern\u00e1ndez-Boluda JC, Czerw T, Barbui T, D\u2019Adda M, Deeg HJ, et al. Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMT. Lancet Haematol. 2023;10:e59\u2013e70. https:\/\/doi.org\/10.1016\/s2352-3026(22)00330-1.","journal-title":"Lancet Haematol"},{"key":"2719_CR2","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.clml.2020.04.015","volume":"20","author":"A Malato","year":"2020","unstructured":"Malato A, Rossi E, Tiribelli M, Mendicino F, Pugliese N. Splenectomy in myelofibrosis: indications, efficacy, and complications. Clin Lymphoma Myeloma Leuk. 2020;20:588\u201395. https:\/\/doi.org\/10.1016\/j.clml.2020.04.015.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2719_CR3","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/ajh.27274","volume":"99","author":"H Ali","year":"2024","unstructured":"Ali H, Bacigalupo A. 2024 update on allogeneic hematopoietic stem cell transplant for myelofibrosis: A review of current data and applications on risk stratification and management. Am J Hematol. 2024;99:938\u201345. https:\/\/doi.org\/10.1002\/ajh.27274.","journal-title":"Am J Hematol"},{"key":"2719_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2022.100964","volume":"7","author":"SB Ponce","year":"2022","unstructured":"Ponce SB, Chhabra S, Hari P, Firat S. Pretransplant splenic irradiation in patients with myeloproliferative neoplasms. Adv Radiat Oncol. 2022;7:100964. https:\/\/doi.org\/10.1016\/j.adro.2022.100964.","journal-title":"Adv Radiat Oncol"},{"key":"2719_CR5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1620\/tjem.228.295","volume":"228","author":"T Ito","year":"2012","unstructured":"Ito T, Akagi K, Kondo T, Kawabata H, Ichinohe T, Takaori-Kondo A. Splenic irradiation as a component of a reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in myelofibrosis with massive splenomegaly. Tohoku J Exp Med. 2012;228:295\u20139. https:\/\/doi.org\/10.1620\/tjem.228.295.","journal-title":"Tohoku J Exp Med"},{"key":"2719_CR6","doi-asserted-by":"publisher","first-page":"8751329","DOI":"10.1155\/2016\/8751329","volume":"2016","author":"E Matsubara","year":"2016","unstructured":"Matsubara E, Yamanouchi J, Kitazawa R, Azuma T, Fujiwara H, Hato T, et al. Usefulness of low-dose splenic irradiation prior to reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in elderly patients with myelofibrosis. Case Rep Hematol. 2016;2016:8751329 https:\/\/doi.org\/10.1155\/2016\/8751329.","journal-title":"Case Rep Hematol"},{"key":"2719_CR7","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/ajh.27252","volume":"99","author":"N Gagelmann","year":"2024","unstructured":"Gagelmann N, Hobbs GS, Campodonico E, Helbig G, Novak P, Schroeder T, et al. Splenic irradiation for myelofibrosis prior to hematopoietic cell transplantation: a global collaborative analysis. Am J Hematol. 2024;99:844\u201353. https:\/\/doi.org\/10.1002\/ajh.27252.","journal-title":"Am J Hematol"},{"key":"2719_CR8","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1080\/10428194.2017.1321747","volume":"58","author":"NS Kalman","year":"2017","unstructured":"Kalman NS, Mukhopadhyay ND, Roberts CH, Chung HM, Clark WB, McCarty JM, et al. Low-dose splenic irradiation prior to hematopoietic cell transplantation in hypersplenic patients with myelofibrosis. Leuk Lymphoma. 2017;58:2983\u20134. https:\/\/doi.org\/10.1080\/10428194.2017.1321747.","journal-title":"Leuk Lymphoma"},{"key":"2719_CR9","doi-asserted-by":"publisher","first-page":"103400","DOI":"10.1016\/j.retram.2023.103400","volume":"71","author":"E Campodonico","year":"2023","unstructured":"Campodonico E, Xue E, Piemontese S, Chiara A, Bruno A, Scorpio G, et al. Splenic irradiation prior to allogeneic transplant conditioning in myelofibrosis: a pilot experience. Curr Res Transl Med. 2023;71:103400 https:\/\/doi.org\/10.1016\/j.retram.2023.103400.","journal-title":"Curr Res Transl Med"},{"key":"2719_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-019-1245-5","volume":"36","author":"G Helbig","year":"2019","unstructured":"Helbig G, Wieczorkiewicz-Kabut A, Markiewicz M, Krzemie\u0144 H, W\u00f3jciak M, Bia\u0142as K, et al. Splenic irradiation before allogeneic stem cell transplantation for myelofibrosis. Med Oncol. 2019;36:16. https:\/\/doi.org\/10.1007\/s12032-019-1245-5.","journal-title":"Med Oncol"},{"key":"2719_CR11","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41409-023-01913-9","volume":"58","author":"JR Bales","year":"2023","unstructured":"Bales JR, Kim HT, Portillo R, Patel C, McAfee S, Dey B, et al. Splenic irradiation prior to allogeneic hematopoietic cell transplantation for patients with myelofibrosis. Bone Marrow Transplant. 2023;58:459\u201361. https:\/\/doi.org\/10.1038\/s41409-023-01913-9.","journal-title":"Bone Marrow Transplant"},{"key":"2719_CR12","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.bbmt.2020.01.010","volume":"26","author":"S Chhabra","year":"2020","unstructured":"Chhabra S, Narra RK, Wu R, Szabo A, George G, Michaelis LC, et al. Fludarabine\/busulfan conditioning-based allogeneic hematopoietic cell transplantation for myelofibrosis: role of ruxolitinib in improving survival outcomes. Biol Blood Marrow Transplant. 2020;26:893\u2013901. https:\/\/doi.org\/10.1016\/j.bbmt.2020.01.010.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2719_CR13","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/s0145-2126(00)00018-7","volume":"24","author":"R Bouabdallah","year":"2000","unstructured":"Bouabdallah R, Coso D, Gonzague-Casabianca L, Alzieu C, Resbeut M, Gastaut JA. Safety and efficacy of splenic irradiation in the treatment of patients with idiopathic myelofibrosis: a report on 15 patients. Leuk Res. 2000;24:491\u20135. https:\/\/doi.org\/10.1016\/s0145-2126(00)00018-7.","journal-title":"Leuk Res"},{"key":"2719_CR14","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s00277-020-04069-4","volume":"99","author":"D Tremblay","year":"2020","unstructured":"Tremblay D, Schwartz M, Bakst R, Patel R, Schiano T, Kremyanskaya M, et al. Modern management of splenomegaly in patients with myelofibrosis. Ann Hematol. 2020;99:1441\u201351. https:\/\/doi.org\/10.1007\/s00277-020-04069-4.","journal-title":"Ann Hematol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02719-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02719-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02719-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T08:09:07Z","timestamp":1764662947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02719-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":14,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2719"],"URL":"https:\/\/doi.org\/10.1038\/s41409-025-02719-7","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This review did not involve human participants, human data, or human tissue. Ethics approval was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}